COMPANY PROFILE
Dioscure Therapeutics SE
SE (European Company)BonnResearch and experimental development on biotechnology
FOUNDED
2019
6+ years active
TRADE REGISTER
HRB 25651
Bonn
INDUSTRY
Research and experimental development on biotechnology
SIZE CLASS
Large enterprise
Key questions answered
What does the company do?
Erforschung, Entwicklung und Vermarktung von neuen Therapeutika gegen infektiöse und immunologische Erkrankungen und medizinischen Produkten einschließlich deren Absatz sowie die Beratung und Beteiligung an anderen Unternehmen.
Who leads it?
Tom Oliver Schorling · Board Member
How large is it?
Large enterprise
How stable is it?
Stability assessment in Plus profile
Business activity
Industry (WZ2008)
Research and experimental development on biotechnology
WZ M72.11
Size class
Large
Industry (WZ2008) (3)
- M72.11Research and experimental development on biotechnology
- M72.19Other research and experimental development on natural sciences and engineering
- M70.22Business and other management consultancy activities
Business purpose
Erforschung, Entwicklung und Vermarktung von neuen Therapeutika gegen infektiöse und immunologische Erkrankungen und medizinischen Produkten einschließlich deren Absatz sowie die Beratung und Beteiligung an anderen Unternehmen.
Legal essentials
- Register entry
- HRB 25651 (Bonn)
- Legal form
- SE (European Company)
- Founded
- 07 Oct 2019
- Share capital
- €1,844,706
- VAT ID
- —
- LEI
- —
- Representation rules
- Ist nur ein Vorstandsmitglied bestellt, so vertritt er alleine. Sind mehrere Vorstandsmitglieder bestellt, so wird die Gesellschaft durch zwei Vorstandsmitglieder oder durch ein Vorstandsmitglied gemeinsam mit einem Prokuristen vertreten.
Annual statements
No public annual statements on file.
Signals
Four dimensions from hard data — age, financials, HRB events, compliance. The ratings themselves are shown in the Plus profile only.
- Continuity1Available in Plus profile
- Financials2Available in Plus profile
- Management3Available in Plus profile
- Legal status4Available in Plus profile
Directors & officers
Executive board
Tom Oliver Schorling
Board Member
Research contacts
AI-powered research for publicly available contacts: name, role, phone, email, LinkedIn.
Available once you sign in
Recent news
AI-powered research across press, social media and job postings from the last six months.
Available once you sign in
Commercial register history
No events on file.
Companies with a similar profile
Dioscuri Biopharmaceuticals GmbH
München
Odyssey Therapeutics GmbH
Frankfurt am Main
CureVac SE
Tübingen
DS-Pharma GmbH
Ibbenbüren
Creative Therapeutics GmbH
Wuppertal
DIAGENICS Group SE Germany
Essen
Diagnomed GmbH
Köln
DermoDyne Holding UG (haftungsbeschränkt)
Kleinmachnow
Symbasis GmbH
Lohmar
Odicare Solutions GmbH
München
DEVELOPERS
Programmatic access
Three ways to access this company's data programmatically:
- AGENT-CARD
Freely accessible, no API key required — a compact JSON summary for agents and crawlers.
- API
Full, authenticated data via the Implisense API v2 (API key required).
- MCP
MCP server live at mcp.implisense.com (FastMCP, Bearer auth) — usable with ChatGPT, Claude, and your own agents.
What the Plus profile adds
The same page, fully populated — plus the research services locked here.
- Revenue, result and equity across every available year
- All four signals with rationale and source
- Contact search: names, roles, phone, email, LinkedIn
- Shareholder list from the official register portal
- News research covering the last six months
- The full commercial register history